LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 16.73 | 770.25 | 1834 | 1664 | 1.1018 | 1.1823 | MN20160304_L02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 18.95 | 770.25 | 1662 | 1832 | 0.9070 | 0.8497 | MN20160304_L02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 18.95 | 770.25 | 2017 | 1832 | 1.1007 | 1.1595 | MN20160304_L02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 21.17 | 770.25 | 1846 | 2008 | 0.9192 | 0.8817 | MN20160304_L02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 21.17 | 770.25 | 2150 | 2008 | 1.0705 | 1.1010 | MN20160304_L02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 23.39 | 770.25 | 2071 | 2244 | 0.9227 | 0.8984 | MN20160304_L02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 23.39 | 770.25 | 2411 | 2244 | 1.0742 | 1.0949 | MN20160304_L02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 25.62 | 770.25 | 2306 | 2514 | 0.9169 | 0.9010 | MN20160304_L02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 25.62 | 770.25 | 2666 | 2514 | 1.0601 | 1.0696 | MN20160304_L02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 27.84 | 770.25 | 2571 | 2833 | 0.9072 | 0.8990 | MN20160304_L02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 27.84 | 770.25 | 3043 | 2833 | 1.0738 | 1.0772 | MN20160304_L02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 30.06 | 770.25 | 2890 | 3106 | 0.9304 | 0.9296 | MN20160304_L02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 30.06 | 770.25 | 3321 | 3106 | 1.0692 | 1.0676 | MN20160304_L02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 32.28 | 770.25 | 3074 | 3392 | 0.9060 | 0.9098 | MN20160304_L02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 32.28 | 770.25 | 3601 | 3392 | 1.0613 | 1.0564 | MN20160304_L02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 34.50 | 770.25 | 3410 | 3712 | 0.9186 | 0.9266 | MN20160304_L02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 34.50 | 770.25 | 3841 | 3712 | 1.0348 | 1.0303 | MN20160304_L02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 36.73 | 770.25 | 3728 | 4086 | 0.9124 | 0.9252 | MN20160304_L02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 36.73 | 770.25 | 4267 | 4086 | 1.0443 | 1.0363 | MN20160304_L02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 38.95 | 770.25 | 4118 | 4543 | 0.9063 | 0.9246 | MN20160304_L02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 38.95 | 770.25 | 4737 | 4543 | 1.0425 | 1.0328 | MN20160304_L02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 41.17 | 770.25 | 4525 | 5010 | 0.9031 | 0.9259 | MN20160304_L02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 41.17 | 770.25 | 5101 | 5010 | 1.0180 | 1.0133 | MN20160304_L02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 43.39 | 770.25 | 4964 | 5404 | 0.9185 | 0.9404 | MN20160304_L02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 43.39 | 770.25 | 5610 | 5404 | 1.0380 | 1.0267 | MN20160304_L02 | N08 |